MyECheck Inc. (MYEC.OB) Strings Together Two Days of Monster Gains
MyECheck Inc. is a financial electronic transaction processor and provider of alternative payment solutions for internet and mobile commerce. In…
Blog
SkyPostal Networks Inc. (SKPN.OB) Recently Announced Over $13 Million in New Financing and Potential for Future Expansion
SkyPostal Networks Inc. is one of the leading private mail networks in Latin America, handling commercial mail, periodicals and parcel…
QuoteMedia Inc. (QMCI.OB) is a Leading Financial Markets Data Provider
QuoteMedia Inc. (QMCI.OB) is a leading provider of financial stock market data, market news feeds, market research information, and financial…
Entrée Gold Inc. (AMEX:EGI) – Strategic Resource Exploration at its Finest
Entrée Gold Inc. (EGI) is an American mining and exploration company with active copper and gold interests in both the…
NW Tech Capital, Inc. (NWTT.OB)’s New Subsidiary Partners Up With Cisco Systems
On Monday, NW Tech. Capital announced that its recently acquired subsidiary, TeleDigit, Inc. had just become a certified registered partner…
Synthetic Blood International (SYBD.OB) Changes Name to Oxygen Biotherapeutics, Inc. (OXBO.OB)
As previously announced in June, Synthetic Blood International has changed its name to Oxygen Biotherapeutics, Inc. effective today. The company…
Dutton Associates Featured Company: Shumate Industries, Inc. (SHMT.OB)
Shumate Industries, Inc. currently consists of two divisions servicing the oil and gas exploration industry. The Shumate Machine Works division…
Dutton Associates Featured Company: SES Solar, Inc. (SESI.OB)
SES Solar, Inc researches, develops, sells, and installs solar energy products, including photovoltaic modules and solar roof tiles. SES Solar’s…
BioShaft Water Technology Inc. (BSHF.OB) Sets Stakes in Qatar through Strategic Agreement
BioShaft Water Technology Inc. (OTCBB: BSHF), developer of innovative wastewater treatment technologies, today announced it has secured an agreement with…
Lev Pharmaceuticals Inc. (LEVP.OB) Granted Authorization to File for European Distribution Rights for Lead Drug Candidate
Lev Pharmaceuticals Inc. (OTCBB: LEVP) develops and commercializes therapeutic products for inflammatory diseases. Its lead product candidate, Cinryze (C1 inhibitor),…